[1] |
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019[J]. CA A Cancer J Clin, 2019, 69(1):7-34.
doi: 10.3322/caac.v69.1
|
[2] |
Johnson DE, Burtness B, Leemans CR, et al. Head and neck squamous cell carcinoma[J]. Nat Rev Dis Primers, 2020, 6(1):92.
doi: 10.1038/s41572-020-00224-3
pmid: 33243986
|
[3] |
Wang Y, Wang SN, Ren Y, et al. The role of lncRNA crosstalk in leading cancer metastasis of head and neck squamous cell carcinoma[J]. Front Oncol, 2020, 10: 561833.
doi: 10.3389/fonc.2020.561833
|
[4] |
Kopp F, Mendell JT. Functional classification and experimental dissection of long noncoding RNAs[J]. Cell, 2018, 172(3):393-407.
doi: 10.1016/j.cell.2018.01.011
|
[5] |
Luo ZG, Han ZY, Shou F, et al. LINC00958 accelerates cell proliferation and migration in non-small cell lung cancer through JNK/c-JUN signaling[J]. Hum Gene Ther Methods, 2019, 30(6):226-234.
doi: 10.1089/hgtb.2019.115
pmid: 31855084
|
[6] |
Yang LH, Li LL, Zhou ZZ, et al. SP1 induced long non-coding RNA LINC00958 overexpression facilitate cell proliferation, migration and invasion in lung adenocarcinoma via mediating miR-625-5p/CPSF7 axis[J]. Cancer Cell Int, 2020, 20: 24.
doi: 10.1186/s12935-020-1099-0
|
[7] |
Chen FY, Liu MY, Yu YX, et al. LINC00958 regulated miR-627-5p/YBX2 axis to facilitate cell proliferation and migration in oral squamous cell carcinoma[J]. Cancer Biol Ther, 2019, 20(9):1270-1280.
doi: 10.1080/15384047.2019.1617571
pmid: 31161900
|
[8] |
Yan HW, Bu PC. Non-coding RNA in cancer[J]. Essays Biochem, 2021, 65(4):625-639.
doi: 10.1042/EBC20200032
pmid: 33860799
|
[9] |
张越, 吴雷, 刘继光. Lnc RNA KCNQ1OT1靶向miR-506-3p调控舌鳞状细胞癌细胞增殖、侵袭和迁移的机制研究[J]. 口腔医学, 2021, 41(3): 204-209.
|
[10] |
Zhang HL, Zhang GM, Zhang F, et al. LINC00958 may be a new prognostic biomarker in various cancers: A meta-analysis and bioinformatics analysis[J]. Front Genet, 2022, 13: 998442.
doi: 10.3389/fgene.2022.998442
|
[11] |
Pastushenko I, Blanpain C. EMT transition states during tumor progression and metastasis[J]. Trends Cell Biol, 2019, 29(3):212-226.
doi: S0962-8924(18)30201-0
pmid: 30594349
|
[12] |
Thierauf J, Veit JA, Hess J. Epithelial-to-mesenchymal transition in the pathogenesis and therapy of head and neck cancer[J]. Cancers, 2017, 9(7):76.
doi: 10.3390/cancers9070076
|
[13] |
Serrano-Gomez SJ, Maziveyi M, Alahari SK. Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications[J]. Mol Cancer, 2016, 15: 18.
doi: 10.1186/s12943-016-0502-x
pmid: 26905733
|
[14] |
Nieto M, Huang RJ, Jackson R, et al. Emt: 2016[J]. Cell, 2016, 166(1):21-45.
doi: 10.1016/j.cell.2016.06.028
pmid: 27368099
|
[15] |
Hashemi M, Hajimazdarany S, Mohan CD, et al. Long non-coding RNA/epithelial-mesenchymal transition axis in human cancers: Tumorigenesis, chemoresistance, and radioresistance[J]. Pharmacol Res, 2022, 186: 106535.
doi: 10.1016/j.phrs.2022.106535
|
[16] |
Pavlič A, Hauptman N, Boštjančič E, et al. Long non-coding RNAs as potential regulators of EMT-related transcription factors in colorectal cancer-asystematic review and bioinformatics analysis[J]. Cancers, 2022, 14(9):2280.
|
[17] |
Liz J, Esteller M. lncRNAs and microRNAs with a role in cancer development[J]. Biochim Biophys Acta, 2016, 1859(1):169-176.
doi: 10.1016/j.bbagrm.2015.06.015
pmid: 26149773
|
[18] |
Salim U, Kumar A, Kulshreshtha R, et al. Biogenesis, characterization, and functions of mirtrons[J]. Wiley Interdiscip Rev RNA, 2022, 13(1):e1680.
|
[19] |
Saliminejad K, Khorram Khorshid HR, Soleymani Fard S, et al. An overview of microRNAs: Biology, functions, therapeutics, and analysis methods[J]. J Cell Physiol, 2019, 234(5):5451-5465.
doi: 10.1002/jcp.27486
pmid: 30471116
|
[20] |
Wang LF, Zhong YB, Yang BH, et al. LINC00958 facilitates cervical cancer cell proliferation and metastasis by sponging miR-625-5p to upregulate LRRC8E expression[J]. J Cell Biochem, 2020, 121(3):2500-2509.
doi: 10.1002/jcb.29472
pmid: 31691355
|